Parents of children with food allergies may experience a greater psychosocial burden when reactions are more frequent or severe and when families follow stricter allergenic food avoidance practices. Medscape Medical...

The drug has been hailed as a breakthrough in managing the deadliest of all the major cancers. Source link : https://www.bbc.com/news/articles/cy82l435171o?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-06-01 02:50:00 Copyright for...

Sudden cardiac death can happen without warning, and it's not just a problem for sporty young men, say experts. Source link : https://www.bbc.com/news/articles/c1l218n82pdo?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-31 23:21:00...

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma. Medscape Medical...

CHICAGO -- A paradigm-changing clinical trial in prostate cancer showed that perioperative apalutamide (Erleada) and androgen deprivation therapy (ADT) significantly reduced the risk of metastasis in high-risk localized disease versus...

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes. Medscape Medical News Source...

"The light goes out of their eyes in about 3 years. This is not what they signed up for." -- Clark Coler, MD, of Swedish Medical Group in Seattle, on...

CHICAGO -- A first-in-class bispecific antibody targeting PD-1 and VEGF combined with chemotherapy significantly improved overall survival (OS) in patients with advanced squamous non-small cell lung cancer (NSCLC), according to...

Donald Trump's physician says the president is in "excellent health" and is "fully fit" to serve as commander in chief after a medical exam Tuesday at Walter Reed National Military...

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy. Medscape Medical News Source link : https://www.medscape.com/viewarticle/will-proteus-change-playbook-radical-prostatectomy-2026a1000i2k?src=rss Author : Publish date : 2026-05-31 19:07:00...

CHICAGO -- Treatment with the CDK4/6 inhibitor abemaciclib (Verzenio) offered a dramatic survival uptick in a highly aggressive soft-tissue cancer that rarely responds to chemotherapy, according to the SARC041 trial....

CHICAGO -- The adjuvant treatment of RET fusion-positive non-small-cell lung cancer (NSCLC) following potentially curative surgery or radiotherapy has a new standard of care, researchers reported here. In a phase...

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold. Medscape Medical News Source link : https://www.medscape.com/viewarticle/abemaciclib-slows-progression-advanced-liposarcoma-2026a1000i2g?src=rss Author : Publish date...

Peptides have moved from bodybuilding forums into the cultural mainstream. Telehealth clinics advertise them for weight loss and recovery, often outside any FDA-approved indication. Podcasters describe their personal protocols to...

CHICAGO -- Men with metastatic castration-sensitive prostate cancer (mCSPC) and DNA repair alterations had significantly longer progression-free survival (PFS) with a targeted drug plus an androgen receptor pathway inhibitor (ARPI),...

Experts at the Primary Care Show identified the key barriers to lipid management — and what clinicians can do about them. Medscape News UK Source link : https://www.medscape.com/viewarticle/tackling-barriers-lipid-management-primary-care-2026a1000i26?src=rss Author :...

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC. Medscape Medical News Source link...

CHICAGO -- RASolute 302 trial results were hailed as a game-changing breakthrough in the treatment of pancreatic cancer. The phase III study showed that second-line daraxonrasib, an investigational oral RAS(ON)...

Rochelle Lewis is among more than 170 million woman globally to be diagnosed with PCOS. Source link : https://www.bbc.com/news/articles/cd9p50j3ljko?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-31 06:13:00 Copyright for syndicated content...

CHICAGO -- Adding an investigational TROP2-targeted antibody-drug conjugate (ADC) to first-line immunotherapy for PD-L1-positive non-small cell lung cancer (NSCLC) reduced the risk of disease progression and may have improved survival...